Brevan Howard Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 12,499 shares of BCRX stock, worth $81,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,499
Previous 70,091
82.17%
Holding current value
$81,493
Previous $419,000
84.96%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
256Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$114 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$85.1 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$66 Million0.65% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.21B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...